Stock data
Profound Medical Corp. (PROF)
Profound Medical Corp. (PROF) reported revenue of US$16.10M and net income of -US$42.57M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | US$16.10M | US$11.39M | -US$41.25M | -US$42.57M | — |
| 2024 | US$9.74M | US$7.04M | -US$33.06M | -US$27.82M | — |
| 2023 | US$5.90M | US$4.31M | -US$28.65M | -US$28.32M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | US$2.48M | -US$9.54M | — |
| 2026-03-31 | US$5.34M | -US$7.05M | — |
| 2025-12-31 | US$6.72M | -US$8.17M | — |
| 2025-09-30 | US$5.06M | -US$7.98M | — |
| 2025-06-30 | US$1.98M | -US$15.70M | — |
| 2025-03-31 | US$2.34M | -US$10.72M | — |
| 2024-12-31 | US$4.03M | -US$4.95M | — |
| 2024-09-30 | US$2.54M | -US$9.37M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.